Molecular Devices, Xsira Pharmaceuticals Inc. deal

MDCC acquired the assets of Xsira's Transfluor imaging technology for $11 million in cash. Xsira (formerly Norak Biosciences) will focus on drug discovery using a license to Transfluor that it receive...